The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

GMTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Gemini Therapeutics Insider Trading History Chart

Gemini Therapeutics Share Price & Price History

^$64.96

▲ +1.45 (2.28%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

Gemini Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/26/2022	Braden Michael Leonard	Major Shareholder	Sell	22,500	$2.09	$47,025.00	247,500
4/13/2022	Braden Michael Leonard	Major Shareholder	Buy	191,769	$1.52	$291,488.88	5,000,000
4/11/2022	Braden Michael Leonard	Major Shareholder	Buy	504,487	$1.35	$681,057.45	4,604,487

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Gemini Therapeutics (NASDAQ:GMTX)

75.42% of Gemini Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Gemini Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2022	Ergoteles LLC	92,200	$0.15M	0.0%	-13.1%	0.213%
11/10/2022	MYDA Advisors LLC	63,000	$0.10M	0.0%	+215.0%	0.146%
11/10/2022	Nantahala Capital Management LLC	257,672	$0.42M	0.0%	N/A	0.596%
11/10/2022	ExodusPoint Capital Management LP	51,779	$85K	0.0%	N/A	0.120%
10/27/2022	Assenagon Asset Management S.A.	82,171	$0.14M	0.0%	+423.2%	0.190%
7/27/2022	Assenagon Asset Management S.A.	15,704	$27K	0.0%	N/A	0.036%
7/15/2022	Marquette Asset Management LLC	87,648	$0.15M	0.0%	+32.3%	0.203%
4/26/2022	Marquette Asset Management LLC	66,269	$92K	0.0%	N/A	0.153%
2/15/2022	Adage Capital Partners GP L.L.C.	682,612	$1.99M	0.0%	-9.9%	1.583%
2/14/2022	Suvretta Capital Management LLC	2,372,267	$6.90M	0.1%	+11.0%	5.502%
2/11/2022	Foresite Capital Opportunity Management V LLC	2,435,125	$7.09M	4.8%	N/A	5.648%
1/28/2022	Allspring Global Investments Holdings LLC	16,257	$47K	0.0%	N/A	0.038%
11/16/2021	Suvretta Capital Management LLC	2,137,823	$8.64M	0.1%	+0.1%	4.959%
11/15/2021	Point72 Asset Management L.P.	93,576	$0.38M	0.0%	-53.2%	0.217%
11/15/2021	Pura Vida Investments LLC	494,400	$2M	0.1%	N/A	1.147%
11/15/2021	Atom Investors LP	102,792	$0.42M	0.0%	N/A	0.238%
11/15/2021	Franklin Resources Inc.	2,512,773	$10.15M	0.0%	+56.5%	5.829%
11/12/2021	Geode Capital Management LLC	473,735	$1.91M	0.0%	+4.3%	1.099%
11/9/2021	BlackRock Inc.	1,249,127	$5.05M	0.0%	-0.7%	2.898%
11/4/2021	Asymmetry Capital Management L.P.	284,079	$1.15M	0.7%	N/A	0.659%
11/1/2021	SG Americas Securities LLC	12,246	$49K	0.0%	N/A	0.028%
8/18/2021	Ikarian Capital LLC	426,455	$2.76M	0.2%	-37.7%	0.991%
8/17/2021	Woodline Partners LP	38,215	$0.25M	0.0%	-88.7%	0.089%
8/17/2021	Millennium Management LLC	255,742	$1.66M	0.0%	-22.5%	0.594%
8/17/2021	Boothbay Fund Management LLC	47,702	$0.31M	0.0%	-37.7%	0.111%
8/16/2021	Point72 Asset Management L.P.	200,000	$1.29M	0.0%	-58.4%	0.465%
8/16/2021	Cubist Systematic Strategies LLC	12,517	$81K	0.0%	N/A	0.029%
8/16/2021	California State Teachers Retirement System	30,248	$0.20M	0.0%	N/A	0.070%
8/16/2021	Alyeska Investment Group L.P.	837,584	$5.42M	0.1%	+55.1%	1.945%
8/16/2021	Morgan Stanley	29,976	$0.19M	0.0%	+22.4%	0.070%
8/16/2021	Charles Schwab Investment Management Inc.	187,123	$1.21M	0.0%	+30.1%	0.435%
8/16/2021	State Street Corp	308,141	$1.99M	0.0%	+1,539.0%	0.716%
8/16/2021	Nuveen Asset Management LLC	62,373	$0.40M	0.0%	N/A	0.145%
8/13/2021	Northern Trust Corp	222,718	$1.44M	0.0%	+289.3%	0.517%
8/13/2021	Franklin Resources Inc.	1,605,600	$10.39M	0.0%	+221.1%	3.729%
8/13/2021	Geode Capital Management LLC	454,195	$2.94M	0.0%	+61.9%	1.055%
8/13/2021	Vanguard Group Inc.	1,747,304	$11.31M	0.0%	-5.5%	4.058%
8/13/2021	FMR LLC	2,905,800	$18.80M	0.0%	+4.2%	6.749%
8/12/2021	Penserra Capital Management LLC	6,575	$42K	0.0%	-50.3%	0.015%
8/12/2021	JPMorgan Chase & Co.	8,410	$54K	0.0%	+180.3%	0.020%
8/11/2021	Bank of New York Mellon Corp	62,555	$0.40M	0.0%	+436.9%	0.145%
8/11/2021	BlackRock Inc.	1,257,596	$8.14M	0.0%	+421.2%	2.921%
8/11/2021	Deutsche Bank AG	54,216	$0.35M	0.0%	+31.6%	0.126%
8/10/2021	Virtus ETF Advisers LLC	19,673	$0.13M	0.1%	N/A	0.046%
8/5/2021	Rhumbline Advisers	19,382	$0.13M	0.0%	N/A	0.045%
8/2/2021	New York State Common Retirement Fund	18,700	$0.12M	0.0%	N/A	0.043%
5/18/2021	Millennium Management LLC	330,019	$4.47M	0.0%	N/A	0.768%
5/18/2021	Opaleye Management Inc.	810,500	$10.98M	1.6%	N/A	1.885%
5/18/2021	Point72 Asset Management L.P.	480,500	$6.51M	0.0%	N/A	1.117%
5/18/2021	Orbimed Advisors LLC	5,826,224	$78.95M	0.7%	N/A	13.550%
5/18/2021	Alyeska Investment Group L.P.	540,121	$6.34M	0.1%	N/A	1.256%
5/18/2021	Boxer Capital LLC	1,300,000	$17.62M	0.6%	N/A	3.023%
5/18/2021	Cormorant Asset Management LP	475,000	$6.44M	0.1%	N/A	1.105%
5/17/2021	Endurant Capital Management LP	169,876	$2.30M	0.6%	N/A	0.395%
5/17/2021	JS Capital Management LLC	474,457	$6.43M	0.3%	N/A	1.103%
5/17/2021	Suvretta Capital Management LLC	1,312,363	$17.78M	0.3%	N/A	3.052%
5/17/2021	Price T Rowe Associates Inc. MD	750,000	$9.65M	0.0%	N/A	1.744%
5/17/2021	DAFNA Capital Management LLC	150,000	$2.03M	0.5%	N/A	0.349%
5/17/2021	Woodline Partners LP	338,305	$4.58M	0.1%	N/A	0.787%
5/17/2021	Ikarian Capital LLC	684,379	$9.27M	0.3%	N/A	1.592%
5/17/2021	Goldman Sachs Group Inc.	39,459	$0.54M	0.0%	N/A	0.092%
5/14/2021	Monashee Investment Management LLC	117,462	$1.59M	0.2%	N/A	0.273%
5/13/2021	Franklin Resources Inc.	500,000	$6.78M	0.0%	N/A	1.163%
5/13/2021	Penserra Capital Management LLC	13,238	$0.18M	0.0%	N/A	0.031%
5/13/2021	Bank of New York Mellon Corp	11,651	$0.16M	0.0%	N/A	0.027%
5/12/2021	Northern Trust Corp	57,208	$0.78M	0.0%	N/A	0.133%
5/12/2021	Geode Capital Management LLC	280,545	$3.80M	0.0%	N/A	0.652%
5/12/2021	MYDA Advisors LLC	63,900	$0.87M	0.2%	N/A	0.149%
5/12/2021	JPMorgan Chase & Co.	3,000	$41K	0.0%	N/A	0.007%
5/7/2021	BlackRock Inc.	241,279	$3.27M	0.0%	N/A	0.561%
5/7/2021	Harvard Management Co. Inc.	250,000	$3.39M	0.2%	N/A	0.581%
5/6/2021	Altium Capital Management LP	203,995	$2.76M	0.8%	N/A	0.474%

Data available starting January 2016

Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $64.96

$62.61

$65.80

50 Day Range

MA: $52.10

$44.82

$66.57

52 Week Range

Now: $64.96

$1.16

$14.10

Volume

282,399 shs

Average Volume

189,291 shs

Market Capitalization

$2.81 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Financial Prophecy

From Porter & Company | Ad

Including the name of the #1 company to buy.